March 15, 2018 / 11:38 AM / 2 years ago

BRIEF-Adaptimmune Therapeutics Reports Quarterly Loss Per Ordinary Share Of $0.05

March 15 (Reuters) - Adaptimmune Therapeutics Plc:

* ADAPTIMMUNE REPORTS FOURTH QUARTER / FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE

* ADAPTIMMUNE THERAPEUTICS PLC QUARTERLY LOSS PER ORDINARY SHARE $0.05

* ADAPTIMMUNE THERAPEUTICS - BELIEVES EXISTING CASH AND CASH EQUIVALENTS, SHORT-TERM DEPOSITS TO FUND CURRENT OPERATING PLAN THROUGH TO EARLY 2020

* ADAPTIMMUNE THERAPEUTICS PLC QUARTERLY REVENUE $4.3 MILLION VERSUS $8.5 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below